The Patent Finder

Unigen Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Unigen Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Unigen Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,852,657Chromones as therapeutic agents
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,362,305Series of Skin Whitening (LIGHTENING) Compounds
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,945,518Formulation of Dual Eicosanoid System and Cytokine System Inhibitors for Use in the Prevention and Treatment of Oral Diseases and Conditions
Formerly held
Term ended
Term ended Oct 8, 2026 · Medium confidence
Term endedTerm ended Oct 8, 2026Medium confidence
US 9,655,940Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
Formerly held
Term ended
Term ended May 19, 2026 · USPTO record
Term endedTerm ended May 19, 2026USPTO record
US 8,592,488Diarylalkanes as potent inhibitors of binuclear enzymes
Formerly held
Term ended
Term ended Aug 31, 2025 · High confidence
Term endedTerm ended Aug 31, 2025High confidence
US 7,678,7727-hydroxy chromones as potent antioxidants
Formerly held
Term ended
Term ended Jul 2, 2025 · USPTO record
Term endedTerm ended Jul 2, 2025USPTO record
US 7,767,661Diarylalkanes as Potent Inhibitors of Binuclear Enzymes
Formerly held
Term ended
Term ended May 27, 2025 · High confidence
Term endedTerm ended May 27, 2025High confidence
US 7,674,830Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
Formerly held
Term ended
Term ended Apr 2, 2025 · USPTO record
Term endedTerm ended Apr 2, 2025USPTO record
US 7,514,469Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
Formerly held
Term ended
Term ended Jul 3, 2024 · USPTO record
Term endedTerm ended Jul 3, 2024USPTO record
US 8,790,724Formulation of Dual Cycloxygenase (COX) and Lipoxygenase (LOX) Inhibitors for Mammal Skin Care
Formerly held
Term ended
Term ended Apr 2, 2024 · High confidence
Term endedTerm ended Apr 2, 2024High confidence
10 of 39 patents shown.
Pro members see all 39.
Pro members: see all 39 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited